“The second phase will begin in about a couple of months. The completion of the first phase will take some time ... Countries can always publish emergency recommendations. But so far (from Remdesivir. - RT ) there is no benefit in reducing mortality. There are no official WHO recommendations regarding the drug, ”she told RIA Novosti.
She added that the completion of the first phase includes effectiveness tests for Remdesivir.
WHO will soon set up a committee to determine which new drugs will be able to take part in the second phase of the trials.
Swaminathan previously stated that Remdesivir is the only antiviral drug so far that has shown “encouraging” results against coronavirus infection COVID-19.
On July 3, the Ministry of Health of Russia approved the second version of guidelines for the treatment of coronavirus infection COVID-19 in children. It is noted that the guidelines “Features of the clinical manifestations and treatment of the disease caused by the new coronavirus infection (COVID-19) in children” were updated taking into account the experience of treating children in Russia and other countries.
The recommendations are published on the website of the ministry, and also sent to the regions for use in clinical practice.